Le Lézard
Classified in: Science and technology, Covid-19 virus
Subjects: SVY, LEG, POL

House Report Calls for Antitrust Law Updates to Address Big Tech Monopolies


WASHINGTON, Oct. 7, 2020 /PRNewswire/ -- After a 16-month long, bipartisan investigation, the House Antitrust, Commercial, and Administrative Law Subcommittee released a report today on the anti-competitive practices of Big Tech companies.

As part of the investigation, the committee held multiple hearings and briefings with experts to ensure they heard a range of viewpoints on how the dominance of Amazon, Apple, Google, and Facebook impacts innovation, privacy, small businesses, and other aspects of the digital marketplace.

In the report, the committee members found that the companies leveraged their dominant positions in their respective spheres to drive out competing companies ? or by buying them up to consolidate their market share. Comparing them to the monopolies of the "era of oil barons and railroad tycoons" the report recommends remedies to restore free and fair competition.

The recommendations include:

"Our nation has a long and proud history of fighting monopolies," said Mike Lux, President of American Family Voices. "There's no question that an open internet has benefited society in many ways, but it is evident that a select few companies have monopolized the industry, allowing them to control huge parts of the economy. This stifles innovation, hurts small businesses, and results in lower wages for workers."

Today people's jobs, shopping and communications are largely online ? a trend that was accelerated by the Covid-19 pandemic, when in-person activities were limited. With this increased dependence on digital platforms comes outsized power and influence in the hands of a few companies. It also comes at the expense of small, brick-and-mortar businesses, many of which have been forced to close or reduce services during the pandemic. Once Covid-19 subsides, consumers may not return to their former in-person habits, which would be devastating to many businesses and local economies.

"Congress needs to rein in the dominance of the big tech companies," commented Lux. "I urge our representatives to adopt the recommendations in the House report and level the competitive playing field in the digital marketplace.

The serious and potentially dangerous implications of the unchecked dominance of these companies include the proliferation of misleading and harmful content and the security of users' personal information. To date, the major digital platforms have not shown a willingness to better regulate themselves, leading lawmakers and advocates to call for reform.

The full report can be found here.

SOURCE American Family Voices


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: